Other Species / Isoforms
  TFCP2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K50-sm
VLALPIFkQEESSLP
0 2
TFCP2 (human) VLALPIFkQEESSLP K50-sm
TFCP2 (mouse) VLALPIFKQEESSLP K50
TFCP2 (rat) VLALPIFKQEESSLP K50
K104-ub
IRMLDNRkLGELPEI
0 2
TFCP2 (human) IRMLDNRkLGELPEI K104-ub
TFCP2 (mouse) IRMLDNRKLGELPEL K104
TFCP2 (rat) IRMLDNRKLGELPEI K104
K114-ub
ELPEINGkLVKSIFR
0 1
TFCP2 (human) ELPEINGkLVKSIFR K114-ub
TFCP2 (mouse) ELPELNGKLVKSIFR K114
TFCP2 (rat) ELPEINGKLVKSIFR K114
K181-ub
EFLWDPAkRTSVFIQ
0 1
TFCP2 (human) EFLWDPAkRTSVFIQ K181-ub
TFCP2 (mouse) EFLWDPSKRTSVFIQ K181
TFCP2 (rat) EFLWDPAKRTSVFIQ K181
T194-p
IQVHCIStEFtMRKH
0 1
TFCP2 (human) IQVHCIStEFtMRKH T194-p
TFCP2 (mouse) IQVHCISTEFTMRKH T194
TFCP2 (rat) IQVHCISTEFTMRKH T194
T197-p
HCIStEFtMRKHGGE
0 2
TFCP2 (human) HCIStEFtMRKHGGE T197-p
TFCP2 (mouse) HCISTEFTMRKHGGE T197
TFCP2 (rat) HCISTEFTMRKHGGE T197
K217-ub
RVQIDTFkENENGEY
0 1
TFCP2 (human) RVQIDTFkENENGEY K217-ub
TFCP2 (mouse) RVQIDTFKENGNGEY K217
TFCP2 (rat) RVQIDTFKENENGEY K217
T258-p
REKMEKRtPHEKEKY
Upstream
1 0
Kinase, in vitro:
  • CDK2 (human)
TFCP2 (human) REKMEKRtPHEKEKY T258-p
TFCP2 (mouse) REKMEKRTPHEKEKY T258
TFCP2 (rat) REKMEKRTPHEKEKY T258
S289-p
EITYVNNsPsPGFNS
Upstream
1 0
Kinase, in vitro:
  • CDK2 (human)
TFCP2 (human) EITYVNNsPsPGFNS S289-p
TFCP2 (mouse) EITYVNNSPSPGFNS S289
TFCP2 (rat) EITYVSNSPSPGFNS S289
S291-p
TYVNNsPsPGFNSSH
Upstream
Downstream
2 1
Effects on Modified Protein
  • activity, inhibited
  • phosphorylation
Effects on Biological Processes:
  • transcription, inhibited
Kinase, in vitro:
  • CDK2 (human)
Regulatory protein:
  • PIN1 (human)
Treatment
  • EGF
  • U0126
TFCP2 (human) TYVNNsPsPGFNSSH S291-p
TFCP2 (mouse) TYVNNSPSPGFNSSH S291
TFCP2 (rat) TYVSNSPSPGFNSSH S291
S309-p
SLGEGNGsPNHQPEP
Upstream
Downstream
2 0
Effects on Modified Protein
  • activity, inhibited
Effects on Biological Processes:
  • cell cycle regulation
  • transcription, inhibited
Kinase, in vitro:
  • CDK2 (human)
  • CDK3 (human)
Putative in vivo kinases:
  • CDK2 (human)
  • CDK3 (human)
Regulatory protein:
  • CCNC (human)
  • p21Cip1 (human)
  • p27Kip1 (human)
  • PIN1 (human)
Treatment
  • EGF
  • serum_starvation
  • U0126
TFCP2 (human) SLGEGNGsPNHQPEP S309-p
TFCP2 (mouse) SLGEGNGSPNHQPEP S309
TFCP2 (rat) SLGEGNGSPNHQPEP S309
S343-p
WLHRNRFstFTRLFT
0 4
TFCP2 (human) WLHRNRFstFTRLFT S343-p
TFCP2 (mouse) WLHRNRFSTFTRLFT S343
TFCP2 (rat) WLHRNRFSTFTRLFT S343
T344-p
LHRNRFstFTRLFTN
0 1
TFCP2 (human) LHRNRFstFTRLFTN T344-p
TFCP2 (mouse) LHRNRFSTFTRLFTN T344
TFCP2 (rat) LHRNRFSTFTRLFTN T344
S353-p
TRLFTNFsGADLLkL
0 2
TFCP2 (human) TRLFTNFsGADLLkL S353-p
TFCP2 (mouse) TRLFTNFSGADLLKL S353
TFCP2 (rat) TRLFTNFSGADLLKL S353
K359-ub
FsGADLLkLTRDDVI
0 1
TFCP2 (human) FsGADLLkLTRDDVI K359-ub
TFCP2 (mouse) FSGADLLKLTRDDVI K359
TFCP2 (rat) FSGADLLKLTRDDVI K359